United States : XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa

Press/Media

Period4 Nov 2019

Media coverage

1

Media coverage

  • TitleUnited States : XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa
    Media name/outletTendersInfo – News
    Country/TerritoryIndia
    Date4/11/19
    PersonsAlice Gottlieb
View all 1
View less